Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting375%
completed125%

Recent Activity

3 active trials
Showing 4 of 4
recruitingnot_applicable

Functional Outcomes and Control Using Synchron BCI - Australia

NCT07533903
recruitingnot_applicable

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT07543367
recruitingnot_applicable

Functional Outcomes and Control Using Synchron BCI - Canada

NCT07446114
completednot_applicable

SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device

NCT03834857

Clinical Trials (4)

Showing 4 of 4 trials
NCT07533903Not Applicable

Functional Outcomes and Control Using Synchron BCI - Australia

Recruiting
NCT07543367Not Applicable

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Recruiting
NCT07446114Not Applicable

Functional Outcomes and Control Using Synchron BCI - Canada

Recruiting
NCT03834857Not Applicable

SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4